Similar articles for PMID: 25261158

Year	Number of Results
1992	1
2000	1
2001	1
2002	1
2004	1
2005	2
2006	2
2007	6
2008	4
2009	3
2010	2
2011	7
2012	5
2013	3
2014	11
2015	7
2016	8
2017	8
2018	16
2019	11
2020	9
2021	4
2022	11
2023	4
2024	1

1

Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci.

Munita JM, Murray BE, Arias CA. Munita JM, et al. Int J Antimicrob Agents. 2014 Nov;44(5):387-95. doi: 10.1016/j.ijantimicag.2014.08.002. Epub 2014 Sep 2. Int J Antimicrob Agents. 2014. PMID: 25261158 Free PMC article. Review.

2

A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.

Chuang YC, Chen PY, Lin CY, Chen YC, Wang JT, Chang SC. Chuang YC, et al. Sci Rep. 2018 Jan 26;8(1):1632. doi: 10.1038/s41598-018-19986-8. Sci Rep. 2018. PMID: 29374204 Free PMC article.

3

[Treatment of vancomycin-resistant enterococcal infections].

Lund LC, Holzknecht BJ, Justesen US. Lund LC, et al. Ugeskr Laeger. 2018 Apr 16;180(16):V07170530. Ugeskr Laeger. 2018. PMID: 29690991 Free article. Review. Danish.

4

Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.

Chuang YC, Lin HY, Chen PY, Lin CY, Wang JT, Chen YC, Chang SC. Chuang YC, et al. Clin Infect Dis. 2017 Apr 15;64(8):1026-1034. doi: 10.1093/cid/cix024. Clin Infect Dis. 2017. PMID: 28329222

5

Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience.

McKinnell JA, Arias CA. McKinnell JA, et al. Clin Infect Dis. 2015 Sep 15;61(6):879-82. doi: 10.1093/cid/civ449. Epub 2015 Jun 10. Clin Infect Dis. 2015. PMID: 26063714 Free PMC article. No abstract available.

6

Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?

King EA, McCoy D, Desai S, Nyirenda T, Bicking K. King EA, et al. J Antimicrob Chemother. 2011 Sep;66(9):2112-8. doi: 10.1093/jac/dkr255. Epub 2011 Jun 22. J Antimicrob Chemother. 2011. PMID: 21697178

7

Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.

Hayakawa K, Martin ET, Gudur UM, Marchaim D, Dalle D, Alshabani K, Muppavarapu KS, Jaydev F, Bathina P, Sundaragiri PR, Rajuri SD, Khatri J, Pogue JM, Lephart PR, Rybak MJ, Kaye KS. Hayakawa K, et al. Antimicrob Agents Chemother. 2014 Jul;58(7):3968-75. doi: 10.1128/AAC.02943-14. Epub 2014 May 5. Antimicrob Agents Chemother. 2014. PMID: 24798267 Free PMC article.

8

Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.

Britt NS, Potter EM, Patel N, Steed ME. Britt NS, et al. Clin Infect Dis. 2015 Sep 15;61(6):871-8. doi: 10.1093/cid/civ444. Epub 2015 Jun 10. Clin Infect Dis. 2015. PMID: 26063715 Free PMC article.

9

Vancomycin-resistant enterococcal bacteremia pharmacotherapy.

Patel R, Gallagher JC. Patel R, et al. Ann Pharmacother. 2015 Jan;49(1):69-85. doi: 10.1177/1060028014556879. Epub 2014 Oct 28. Ann Pharmacother. 2015. PMID: 25352037 Review.

10

Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.

Chuang YC, Lin HY, Chen PY, Lin CY, Wang JT, Chang SC. Chuang YC, et al. Clin Microbiol Infect. 2016 Oct;22(10):890.e1-890.e7. doi: 10.1016/j.cmi.2016.07.018. Epub 2016 Jul 27. Clin Microbiol Infect. 2016. PMID: 27475738 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year